A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
12/09/2020 | Sponsored by Roche
An increasing number of clinical laboratories are using next generation sequencing (NGS) for the molecular characterization of cancer.
12/02/2020 | Sponsored by Invitae
ArcherDX , now Invitae is a leading genomics company democratizing precision oncology.
11/11/2020 | Sponsored by Paige
Prostate cancer, the most frequently diagnosed cancer in 105 countries and the leading cause of death in 46 countries worldwide, is diagnosed by core needle biopsy.
11/04/2020 | Sponsored by Adaptive Biotechnologies
clonoSEQ® Assay is a highly sensitive, specific, and standardized method for detecting and monitoring minimal residual disease (MRD).
10/01/2020 | Sponsored by QIAGEN
Targeted NGS has been instrumental in driving our understanding of disease.
09/26/2020
The Pathologist is delighted to introduce the Pathologists’ Assistants: Bridging the Gap Live Roundtable.
09/23/2020 | Sponsored by Thermo Fisher Scientific
The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.
08/26/2020 | Sponsored by Sectra
Region Skåne (Sweden) has implemented digital pathology in 4 labs across their enterprise.
08/20/2020 | Sponsored by Illumina
Clinical trials are increasingly using liquid biopsy samples to complement or as an alternative to invasive tissue sample collections.
08/02/2020 | Sponsored by Ultivue
Targeting of the programmed cell death protein (PD-1)/ programmed death-ligand 1 (PD-L1) axis with checkpoint inhibitors has changed clinical practice in non-small cell lung cancer (NSCLC).
06/22/2020 | Sponsored by Akoya Biosciences
During this webinar, we will demonstrate a novel in situ detection strategy to better characterize the inflammatory burden during kidney and cardiac allograft rejection by targeting NK cells, T lymphocytes and macrophages.
06/16/2020 | Sponsored by Indica Labs
Indica Labs is proud to introduce our HALO AP, state-of-the-art anatomic pathology software.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology